SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027499
Filing Date
2013-05-09
Accepted
2013-05-09 17:15:29
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM10-Q v343144_10q.htm 10-Q 224829
2 EXHIBIT 31.1 v343144_ex31-1.htm EX-31.1 9704
3 EXHIBIT 31.2 v343144_ex31-2.htm EX-31.2 9692
4 EXHIBIT 32.1 v343144_ex32-1.htm EX-32.1 4138
5 EXHIBIT 32.2 v343144_ex32-2.htm EX-32.2 4137
  Complete submission text file 0001144204-13-027499.txt   1441100

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20130331.xml EX-101.INS 113988
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20130331.xsd EX-101.SCH 17759
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20130331_cal.xml EX-101.CAL 29313
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20130331_def.xml EX-101.DEF 40296
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20130331_lab.xml EX-101.LAB 214790
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20130331_pre.xml EX-101.PRE 96280
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 13829974
SIC: 2836 Biological Products, (No Diagnostic Substances)